Communicable E63: Does oseltamivir harm critically ill patients? The REMAP-CAP results
At the Critical Care Reviews meeting in Belfast in June this year, REMAP-CAP investigators presented results suggesting that oseltamivir may be harmful in critically ill patients with influenza, upend...
20 Sep 1h 3min
Communicable E62: The 'prose' and cons of the POET trial – early oral antibiotic switch for endocarditis
In this episode of Communicable, Emily McDonald and Josh Davis host Henning Bundgaard and Sami El-Dalati for a discussion on early oral antibiotic switch for endocarditis, focusing on the POET trial, ...
6 Sep 52min
Communicable E61: We will make you love PK/PD, part 3
In this episode of Communicable, Amy Legg (Brisbane, Australia), Rekha Pai Mangalore (Melbourne, Australia) & Angela Huttner (Geneva, Switzerland) return for the third part of the ‘We will make you lo...
23 Aug 52min
Communicable E60: Quarterly catch-up (August 2026 edition)
In the second edition of 'Quarterly catch-up', CMI Communications editors Emily McDonald and Erin McCreary round-up the biggest news in infectious diseases and review clinical microbiology and infecti...
9 Aug 49min
Communicable E59: 'Ask me anything' – EUCAST and CLSI leadership explain
In this episode of Communicable, Nav Narayanan and Thomas Tängdén kick off the first 'Ask me anything' episode, inviting EUCAST and CLSI leadership Sören Gatermann, Christian Giske and Amy Mathers to ...
26 Juli 1h 9min
Communicable E58: Reducing hospital-acquired pneumonia – the HAPPEN trial and how it happened
In this episode of Communicable, Angela Huttner and Josh Davis are joined by Brett Mitchell, Aline Wolfensberger and Lauren Clack to discuss the HAPPEN trial to prevent hospital-acquired pneumonia led...
12 Juli 54min
Communicable E57: We will make you love PK/PD, part 2
In this episode of Communicable, Thomas Tängdén and Rekha Pai Mangalore return for part 2 of the ‘We will make you love PK/PD’ series. In this round, they are joined by Iris Minichmayr (Austria) and P...
28 Juni 47min
